Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9NQC3 (
Nogo
)
1,062
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inhibitory proteins, particularly
Nogo
66, a highly conserved 66-amino-acid loop of
Nogo
A (an isoform of RTN4), play key roles in limiting the intrinsic capacity of the central nervous system (CNS) to regenerate after injury. Ligation of surface
Nogo
receptors (NgRs) and/or leukocyte immunoglobulin-like receptor B2 (LILRB2) and its mouse orthologue the paired immunoglobulin-like receptor B (PIRB) by
Nogo
66 transduces inhibitory signals that potently inhibit neurite outgrowth. Here, we show that soluble
leukocyte immunoglobulin-like receptor A3
(
LILRA3
) is a high-affinity receptor for
Nogo
66, suggesting that
LILRA3
might be a competitive antagonist to these cell surface inhibitory receptors. Consistent with this,
LILRA3
significantly reversed
Nogo
-66-mediated inhibition of neurite outgrowth and promoted synapse formation in primary cortical neurons through regulation of the ERK/MEK pathway.
LILRA3
represents a new antagonist to
Nogo
-66-mediated inhibition of neurite outgrowth in the CNS, a function distinct from its immune-regulatory role in leukocytes. This report is also the first to demonstrate that a member of LILR family normally not expressed in rodents exerts functions on mouse neurons through the highly homologous
Nogo
66 ligand.
...
PMID:Soluble LILRA3 promotes neurite outgrowth and synapses formation through a high-affinity interaction with Nogo 66. 2682 87